The primary objective is to evaluate the safety of once daily use of LEO 90100 in adolescent subjects aged 12 to 17 years with plaque psoriasis on the body and scalp
Data and Resources
- Safety and Effect of LEO 90100 aerosol foam on the HPA Axis and Calcium Metabolism in Adolescent Subjects Aged 12 to 17 Years with Plaque Psoriasis A phase 2 trial evaluating the safety and efficacy of once daily topical treatment with LEO 90100...json
The primary objective is to evaluate the safety of once daily use of LEO...
|Release Date|| |
License Not Specified
|Public Access Level|| |